SLFN12-PDE3A Complex Inducer BAY 2666605

**Semantic type:** Pharmacologic Substance

**Definition:** An orally bioavailable agent that triggers the formation of a complex of the two proteins Schlafen family member 12 (SLFN12) and phosphodiesterase 3A (PDE3A), with potential antineoplastic activity. Upon oral administration, SLFN12-PDE3A complex inducer BAY2666605 triggers the formation of the SLFN12-PDE3A complex. This stabilizes SLFN12 and alters the expression of a set of genes that regulate cell survival, death, and proliferation. This suppresses cell cycle progression and induces apoptosis in cancer cells that specifically express elevated levels of both of these proteins.

**Synonyms:** - BAY 2666605 - BAY-2666605 - BAY-2666605 - BAY2666605 - SLFN12/PDE3A Complex Inducer BAY 2666605 - Schlafen12 Complex Inducer BAY 2666605